Get Started with NeoGenomics
IHC & ISH
NeoTYPE® Cancer Profiles
NeoGenomics Laboratories is a leader in precision diagnostics and is at the forefront of PD-L1/PD-1 immunotherapy testing. Our broad offering, depth of pathology expertise, and flexible testing options make us an ideal partner for your clinical or research testing needs.
Recorded: July 27, 2017
PD-L1 testing is an immunohistochemical assay that detects the level and expression sites of PD-L1 protein. As a companion or complementary diagnostic for certain tumors and indications, it helps identify patients for treatments including KEYTRUDA®, OPDIVO®, TECENTRIQ® and IMFINZI™.